Genomic Health, Quest Diagnostics Company Profiles in Esoteric Testing Market|Key Players: Myriad Genetics, Invitae, ARUP Laboratories, OPKO Health, Inc., Mayo Medical Laboratories

Infectious disease business segment dominated the esoteric testing market in 2017 with around 28% market share followed by endocrinology, anticipated to witness considerable growth over the coming years. Rising incidences of infectious diseases coupled with growing demand for advanced molecular tests for identifying rare molecules present in the body will drive segment growth. Rising awareness about pre-disease diagnosis and treatment will further stimulate demand for esoteric tests over the coming years.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1922

RT-PCR business segment of esoteric testing market is estimated to witness around 9.6% CAGR growth over the forecast period. Growing adoption and application of real-time PCR as compared to other conventional techniques due to its superior specificity, sensitivity and speed with reduced contamination risk will drive segment growth. Technological advancements in field of PCR coupled with growing investments towards PCR-based research will further propel business growth.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
1.Genomic Health
2.Quest Diagnostics
3.Myriad Genetics
4.Invitae
5.ARUP Laboratories
6.OPKO Health, Inc.
7.Mayo Medical Laboratories
8.ACM Global Laboratories
9.Fulgent Genetics
10.American Esoteric Laboratories

Rising number of people suffering from rare diseases has escalated burden on healthcare systems to develop innovative test solutions, thereby fueling industry growth. Furthermore, sophistication of laboratory equipment leading to growing adoption of ground breaking technologies such as flow cytometry, mass spectrometry and real time-PCR will favor industry growth. Growing awareness about early disease detection along with rising demand for genomics and proteomic will positively impact esoteric testing market growth over the forecast period.

However, lack of trained professionals and stringent regulations related with esoteric tests will restrain industry growth in future.
Germany esoteric testing market should grow with more than 8.5% CAGR growth rate owing to increasing incidences of rare and complex diseases and high cutting edge technological adoption. Germany has well developed National Rare Disease Plan with centralized core programs for neonatal screening, national funding, access to treatments, robust research plans, coordinated networks and cross-border collaborations for rare diseases should propel industry growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1922

Developing healthcare infrastructure, growing awareness about early disease detection and numerous initiatives undertaken by government will drive Indian esoteric testing market. Initiatives such as action plan to eradicate Visceral leishmaniasis (VL) by 2017 undertaken by government will fuel industry growth. Furthermore, increasing elderly population in the country will stimulate demand for esoteric tests over the coming years.

Esoteric Testing Market by Test-type
o Endocrinology
o Infectious disease & immunology
o Oncology
o Toxicology
o Neurology
o Genomics

Esoteric Testing Market by Technology
o Mass spectrometry
o Flow cytometry
o ELISA
o Radioimmunoassay
o Chemiluminescence
o RT-PCR

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.